BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elia D, Caminati A, Zompatori M, Cassandro R, Lonati C, Luisi F, Pelosi G, Provencher S, Harari S. Pulmonary hypertension and chronic lung disease: where are we headed? Eur Respir Rev 2019;28:190065. [DOI: 10.1183/16000617.0065-2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Harari S, Adir Y, Humbert M. Rare pulmonary disease and orphan drugs: a path to the future. Eur Respir Rev 2019;28:190115. [PMID: 31578214 DOI: 10.1183/16000617.0115-2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Khalid Y, Dasu N, Zafar RF, Suga H, Dasu K, Blair B. In-Hospital Outcomes of Patients With Pulmonary Hypertension and Cirrhosis: A 6-Year Population Cohort Study of Over One Million Patients. Cardiol Ther 2020;9:479-92. [PMID: 32691247 DOI: 10.1007/s40119-020-00192-5] [Reference Citation Analysis]
3 Lee SN, Ko SH, Her SH, Han K, Moon D, Kim SK, Yoo KD, Ahn YB. Association between lung function and the risk of atrial fibrillation in a nationwide population cohort study. Sci Rep 2022;12:4007. [PMID: 35256653 DOI: 10.1038/s41598-022-07534-4] [Reference Citation Analysis]
4 Dwivedi K, Sharkey M, Condliffe R, Uthoff JM, Alabed S, Metherall P, Lu H, Wild JM, Hoffman EA, Swift AJ, Kiely DG. Pulmonary Hypertension in Association with Lung Disease: Quantitative CT and Artificial Intelligence to the Rescue? State-of-the-Art Review. Diagnostics (Basel) 2021;11:679. [PMID: 33918838 DOI: 10.3390/diagnostics11040679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, Kalman JM, Heidbuchel H, Nattel S, Wesseling G, Schotten U, van Gelder IC, Franssen FME, Sanders P, Crijns HJGM, Linz D. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J 2021;42:532-40. [PMID: 33206945 DOI: 10.1093/eurheartj/ehaa822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Harari S, Elia D. Should we rewrite the natural history and prognosis of pulmonary Langerhans cell histiocytosis? Eur Respir J 2022;59:2200700. [PMID: 35618281 DOI: 10.1183/13993003.00700-2022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rudyk O, Aaronson PI. Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension. Adv Exp Med Biol 2021;1303:209-41. [PMID: 33788196 DOI: 10.1007/978-3-030-63046-1_13] [Reference Citation Analysis]
8 Jiang Q, Liu C, Liu S, Lu W, Li Y, Luo X, Ma R, Zhang C, Chen H, Chen Y, Zhang Z, Hong C, Guo W, Wang T, Yang K, Wang J. Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats. Br J Pharmacol 2021;178:203-16. [PMID: 33080042 DOI: 10.1111/bph.15285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Hu F, Liu H, Wang C, Li H, Qiao L. Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis. Exp Ther Med 2022;23:108. [PMID: 34976150 DOI: 10.3892/etm.2021.11031] [Reference Citation Analysis]
10 Skuland T, Låg M, Gutleb AC, Brinchmann BC, Serchi T, Øvrevik J, Holme JA, Refsnes M. Pro-inflammatory effects of crystalline- and nano-sized non-crystalline silica particles in a 3D alveolar model. Part Fibre Toxicol 2020;17:13. [PMID: 32316988 DOI: 10.1186/s12989-020-00345-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
11 Santos-Martínez LE, Gómez-Tejada RA, Murillo-Jauregui CX, Hoyos-Paladines RA, Poyares-Jardim CV, Orozco-Levi M. [Chronic exposure to altitude. Clinical characteristics and diagnosis]. Arch Cardiol Mex 2021;91:500-7. [PMID: 33765369 DOI: 10.24875/ACM.20000447] [Reference Citation Analysis]
12 Harel F, Nguyen QT, Nsaibia MJ, Finnerty V, Morgan A, Sirois M, Villeneuve L, Calderone A, Bergeron A, Brochiero E, Tardif JC, Shi Y, Dupuis J. SPECT imaging of pulmonary vascular disease in bleomycin-induced lung fibrosis using a vascular endothelium tracer. Respir Res 2021;22:240. [PMID: 34481508 DOI: 10.1186/s12931-021-01836-3] [Reference Citation Analysis]